Event
DTU Skylab: Applied AI Lunch Talk
Location
Date
Organizer
About Applied AI Lunch Talks
Talk 1
Using AI to Design Smarter DNA for the Future of Biotechnology
Technology and economic drivers of modern biotechnology include AI as well as the automated reading and writing of DNA. Along with the popularization of advanced genetic engineering approaches, e.g. CRISPR, a new era of bioengineering has begun where we are no longer limited by the “cut and paste” of naturally occurring genes and sequences, but rather by our ability to design novel functional DNA, engineered genomes, and synthetic organisms. AI approaches used by Tailwind Biotech are addressing specific design challenges used for engineering improved protein production in host organisms.
Speaker
Christopher Workman CSO and Co-founder of Tailwind Biotech
After 20 years of academic research in systems and synthetic biology, Chris transitioned to the startup world when he co-founded Tailwind Biotech. He led the Fungal Systems Biology group at DTU Bioengineering for much of his time at DTU, where he has applied computational and systems biology to problems in applied biotechnology.
Talk 2
How Generative AI is Accelerating R&D Cycles in Biotech Industry
Every year, cancer and other serious diseases claim 10 million lives. Even a one-year acceleration in research could save millions of lives. In this talk, we will explore how generative AI workflows are transforming life sciences by enabling researchers to analyze experimental data and publications 10x faster. You will gain insights into how AI-powered platforms, like digital scientists, are addressing bottlenecks in drug discovery and reshaping R&D processes. Join us as we discuss the digital revolution in life sciences and what it means for the future of AI in tackling the world’s most pressing health challenges.
Speaker
Bogumil Zimon, CEO & Founder of PharosBio
Bogumil holds a degree in Pharmaceutical Design & Engineering from DTU. He has worked at the forefront of biotech and AI, tackling microbial resistance at Proteon Pharmaceuticals, developing new contraceptives at Cirqle, and advancing computer vision in life sciences at VisioPharm. Now, at PharosBio, he leverages his expertise to drive AI-powered innovations in the life sciences industry.